1 / 2

Aurobindo Pharma jumps 3% | Trade Nivesh

Trade NIvesh : Pharma shares were trading higher in Friday's morning session with their sectoral index trading higher. <br>if you want to make position in future market BUY AUROPHARMA FUTURE ABOVE 826 TG 850, 880 SL 812

Download Presentation

Aurobindo Pharma jumps 3% | Trade Nivesh

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Share Market Update Nifty Pharma index up; Aurobindo Pharma jumps 3% Trade NIvesh : Pharma shares were trading higher in Friday's morning session with their sectoral index trading higher. Shares of Aurobindo PharmaNSE 3.57 % (up 3.38 per cent), CiplaNSE 2.50 % (up 2.74 per cent), Glenmark PharmaceuticalsNSE 1.76 % (up 1.95 per cent) and Sun Pharmaceutical Industries (up 1.58 per cent) were trading with gains. Cadila Healthcare (up 1.48 per cent), Lupin (up 1.32 per cent), Divi's Laboratories (up 1.05 per cent) and Dr. Reddy's Laboratories (up 0.52 per cent) too were trading higher.

  2. The Nifty Pharma index was trading 1.28 per cent up at 9563.25 around 10:15 am. Benchmark NSE Nifty50 index was up 41.15 points at 11,682.95 while the BSE Sensex was up 104.46 points at 38,835.32. Among the 50 stocks in the Nifty index, 32 were trading in the green, while 18 were in the red. Shares of Tata Steel, YES Bank, Vodafone Idea, Tata Motors, SAIL, Axis Bank, DLF, Ashok Leyland, Vedanta and Indian Oil Corp were among the most traded shares on the NSE.

More Related